Antibody formulation

Details for Australian Patent Application No. 2007215012 (hide)

Owner ImClone Systems Incorporated

Inventors Srivastava, Arvind; Goldstein, Joel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007215012

PCT Pub. Number WO2007/095337

Priority 60/774,101 15.02.06 US

Filing date 15 February 2007

Wipo publication date 23 August 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/095337 Priority application(s): WO2007/095337

13 August 2009 Assignment before Grant

  ImClone Systems Incorporated The application has been assigned to ImClone LLC

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007215013-Functional antibodies

2007215005-Novel tricyclic dihydropyrazines as potassium channel openers